ESMO Sarcoma & GIST 2020 - Preparatory Information for Industry

To get up to speed with your preparation for ESMO Sarcoma & GIST Symposium 2020, please download our Industry Guidelines below.

Download the ESMO Sarcoma & GIST Industry Guidelines

Other relevant information will be added to this page and don’t forget to bookmark us for easy access.

Third-party media activities

Media activities initiated by third parties during or in connection with ESMO Sarcoma & GIST Symposium 2020, including, but not limited to:

  • Meetings such as press conferences, media briefings, educational sessions for media representatives, as well as
  • PR activities, such as press releases, news, articles, interviews, etc. 

are subject to the   ESMO Policy on Third-Party Media Activities. This policy aims to guarantee proper and correct distribution of oncology and cancer-related information to media representatives in connection with the conference. 

Press events in or outside the congress centre but concomitant with/or during breaks of the scientific programme of ESMO Sarcoma & GIST Symposium 2020 are subject to ESMO Press Office approval. Please contact media@esmo.org

Official Italian agency for AIFA procedure

AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.

Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the even.

ESMO advises pharmaceutical companies to contact the Official Agency:

AIM Group International – AIM Education S.r.l.
Contact: Valentina Disabato/ Crisitina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mail: aifa@aimgroup.eu